A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder (OCD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2009 by Parkway Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
James G.Sullivan, MD, Parkway Medical Center
ClinicalTrials.gov Identifier:
NCT00997087
First received: October 14, 2009
Last updated: May 30, 2012
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)